Company / Operating Cash Flow per Share
Glaukos Corp. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.26
FY2025
5-year range
-$1.25 / $0.55
FY2021-FY2025
Trend
+79.0%
vs FY2024
Sector context
#138 of 155
Health Care
What the data says
Glaukos Corp.'s operating cash flow per share of $-0.26 is lower than 89% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $-0.26.
Based on SEC 10-K filings.
-0.26 in FY2025.
Improved from $-1.21 to $-0.26 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 155This company -$0.26 Sector average $6.77
▼
-103.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 79.0% year-over-year.
- Ranks #138 out of 155 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2017.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.26 | +79.0% |
| FY2024 | -$1.25 | -3.2% |
| FY2023 | -$1.21 | -71.7% |
| FY2022 | -$0.70 | -229.0% |
| FY2021 | $0.55 | +203.3% |
| FY2020 | -$0.53 | -5070.8% |
| FY2019 | -$0.01 | -101.9% |
| FY2018 | $0.54 | -29.1% |
| FY2017 | $0.77 | +101.0% |
| FY2016 | $0.38 | +142.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026